Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Science Signaling|September 8, 2016
AML suppresses hematopoiesis by releasing exosomes that contain microRNAs targeting c-MYBNoah I Hornick, Ben Doron, Sherif Abdelhamed, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2003
Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic miceArthur A Vandenbark, Cathleen Rich, Jeff Mooney, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2004
Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switchJianya Huan, Sandhya Subramanian, Richard Jones, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 8, 2008
MHC class II derived recombinant T cell receptor ligands protect DBA/1LacJ mice from collagen-induced arthritisJianya Huan, Laurie J Kaler, Jeffery L Mooney, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 16, 2007
A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNSSushmita Sinha, Sandhya Subramanian, Thomas M Proctor, et al.Journal of Neuroscience Research|June 14, 2005
Decreased FOXP3 levels in multiple sclerosis patientsJianya Huan, Nicole Culbertson, Leslie Spencer, et al.Journal of Neuroimmunology|June 16, 2010
Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitisSushmita Sinha, Lisa Miller, Sandhya Subramanian, et al.Journal of Autoimmunity|October 3, 2012
A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell toleranceArthur A Vandenbark, Roberto Meza-Romero, Gil Benedek, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2006
Recombinant HLA-DP2 binds beryllium and tolerizes beryllium-specific pathogenic CD4+ T cellsAndrew P Fontenot, Timothy S Keizer, Mark McCleskey, et al.Journal of Neuroscience Research|September 8, 2004
T-cell hybridoma specific for myelin oligodendrocyte glycoprotein-35-55 peptide produced from HLA-DRB1*1501-transgenic miceYuan K Chou, Nicole Culbertson, Cathleen Rich, et al.Pageof 3